MIM
ALDX icon

Monashee Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History

Monashee Investment Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-146,584
Closed -$1.66M – 271
2021
Q2 		$1.66M Buy
+146,584
New +$1.76M 0.2% 148
2018
Q3 		– Hold
0
– – – 92
2017
Q3 		– Hold
0
– – – 71

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Monashee Investment Management's ALDX Position: Q3 2021 in Review

Monashee Investment Management sold out of Aldeyra Therapeutics (ALDX) in Q3 2021, closing a stake of 146,584 shares — an estimated $1.66M sold.

Monashee Investment Management first reported a position in ALDX in Q2 2021 and held it in 1 quarter. The position peaked at $1.66M in Q2 2021. 117 funds tracked by Wall St. Rank hold ALDX as of Q3 2021.

  • Monashee Investment Management reported no remaining Aldeyra Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Monashee Investment Management sold 146,584 Aldeyra Therapeutics shares in Q3 2021, an estimated $1.66M.
  • Monashee Investment Management first reported a position in Aldeyra Therapeutics in Q2 2021 and held it in 1 quarter.
  • Monashee Investment Management's Aldeyra Therapeutics position peaked at $1.66M in Q2 2021.
  • 117 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2021.

Based on Monashee Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.